Malignant Diseases of The Lung: Surgical Treatment of Lung Metastases

Schil PEYV, Hengst WA, Allen MS, Putnam JB. Pulmonary Metastases. Ch: 16, pp1383-412. In: LoCicero J. Feins RH. Colson YL. Rocco G (editors). Shields General Thoracic Surgery. 8th, 2019. Wolters Kluwer.

Li Y, Zhang W, Li S, Tu C. Clinical efficiency of repeated pulmonary metastasectomy in sarcoma patients with recurrent pulmonary metastasis: A meta-analysis. Cancer Res Ther: 2018; Jun 14:457-62.

Karacam V. Akciğer Metastazlarında Cerrahi Tedavi. Ch: 40, pp:465-72. In: Yüksel M. Balcı AE (editors). Göğüs Cerrahi Kırmızı Kitap 2nd, 2015. Nobel Tıp.

Akatsuka T, Wada T, Kokai Y, Sawada N, Yamawaki S, Ishii S. Loss of ErbB2 Expression in Pulmonary Metastatic Lesions in Osteosarcoma. Oncology 2001;60:361–366

Tanju S.Akciğer Metastazlarında Cerrahi Tedavi. Ch: 33, pp 463-70. In: Okten I. Kavukcu HS (editors). Göğüs Cerrahisi 2nd, 2013. Istanbul Tıp Kitapevi.

Treasure T. Surgery and ablative techniques for lung metastases in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) trial: is there equivalence?J Thorac Dis 2016;8:649-51.

Shin JW, Lee S, Moon HY. Significance of Follow-up in Detection of Pulmonary Metastasis of Colorectal Cancer. J Korean Soc Coloproctology 2010;26(4): 293-97.

Treasure T, Farewell V, Macbeth F, Monson K, et. al. Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial. Trials 2019;20:718

Kim HK, Cho JH, Lee HY, Lee Jeeyun, Kim J. Pulmonary metastasectomy for colorectal cancer: How many nodules, how many times? World J Gastroenterol 2014;20: 6133-45.

Jeffery M, Hickey BE, Hider PN, See AM. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2016;11:CD002200.

Briccoli A, Rocca M, Salone M, Bacci G, et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 2005;104:1721‐5.

Chudgar NP, Brennan MF, Munhoz RR, Bucciarelli PR, et al. Pulmonary Metastasectomy with Therapeutic Intent for Soft Tissue Sarcoma. J Thorac Cardiovasc Surg 2017;154:319-30.

lter S, Cheufou D, Ketscher C, Darwiche K, et al. Risk factors for impaired lung function after pulmonary metastasectomy: A prospective observational study of 117 cases. Eur J Cardiothorac Surg 2012;42:22‐7.

Lindner LH, Litiere S, Sleijfer S, Benson C, et. al. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG). Int J Cancer 2018;142:2610-620.

Durnalı AG, Turkoz FP, Yukruk FA, Tokluoglu S, et. al. Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups. PLos One 2016;11:e0152621.

Yamamoto Y, Kanzaki R, Kanou T, Ose N, et. al. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma. Int JClin Oncol 2019;24:863-70.

Mizuno T, Taniguchi T, Ishikawa Y, Kawaguchi K, et. al. Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment? Eur J Cardiothorac Surg 2013;43:795-99.

Zisman A, Chao DH, Pantuck AJ, Kim JA, J.A. Wieder, et. al. Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype. J Urol. 2002;168:950-955.

Zhao Y, Li J, Li C, Fan J, Liu L. Prognostic factors for overall survival after lung metastasectomy in renal cell cancer patients: A systematic review and Meta-analysis. Int J Surg 2017;41:70-77.

Tyrell R, Antia C, Stanley S, Deutsch GB. Surgical resection of metastatic melanoma in the era of immunotherapy and targeted therapy. Melanoma Manag 2017;4:61–68.

Elias ML, Behbahani S, Maddukuri S. John AM, et. al. Prolonged overall survival following metastasectomy in stage IV melanoma. J Eur Acad Dermatol Venerol 2019;33(9):1719-25.

Database 2014 Annual Report. The European Society of Thoracic Surgeons. www.ests.org

Schlijper RC, Grutters JP, Houben R, Digemans A, et. al. What to choose as radical local treatment for lung metastases from colorectal cancer: surgery or radiofrequency ablation? Cancer Treat. Rev 2014;40:60-67.

Prudhomme C, Deschamps F, Moulin B, Hakime A, et. al. Image guided lung metastasis ablation: a literature review. Int J Hyperthermia 2019;36(2):37-45.

Baere T, Tselikas L, Woodrum D, Abtin F, et. al. Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial -Interim Analysis at 1 Year. Thorac Oncol 2015;10:1468-74.

Alshafa F, Arifin AJ, Rodrigues GB, Palma DA, Louie AV. A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead? Front Oncol 2019;9:543.